Search Results

Site Search

Elevating accuracy of Alzheimer's testing - Insights

Learn how Mayo Clinic Laboratories Alzheimer’s disease testing provides clearer answers for more patients by offering the highest level of overall accuracy for the detection of amyloid pathology.

Stories - Insights

Beyond the test result Mayo Clinic Laboratories combines the expertise of world-renowned laboratorians and physicians to provide answers for patients’

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. - Insights

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating...

Autoimmune profile updates - Insights

Based on studies that have shown certain antibodies may not be as clinically relevant to autoimmune testing as previously thought, Mayo Clinic Laboratories is updating a number of its autoimmune profiles by removing some antibodies from...

The Value Stream of an Outreach Program - Insights

When considering the outreach laboratory value stream, it is important to remember that without quality, there is no value. Through identifying sources for error or non-value-added activities, the hospital laboratory outreach program can...

Education - Insights

Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and

Mass spectrometry-based assay detects viral antigens directly from clinical specimens - Insights

In a newly published study, a team from Mayo Clinic’s Advanced Diagnostics Laboratory has developed a mass spectrometry-based assay that’s able to detect COVID-19 (SARS-CoV-2) pathogens from human proteins with, remarkably, 98% sensitivity...

Rare Lyme disease-causing bacteria spotted on routine blood films - Insights

It’s been understood for some time that an infection of B. mayonii, a rare species of bacterium, results in high levels of spirochetes in the peripheral blood. But actually being able to visualize them on a routine peripheral blood smear...

Leveraging Lessons from the Past - Insights

Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.

Mayo Clinic Develops First-in-U.S. Neurology Test to Distinguish Spectrum of Autoimmune Demyelinating Diseases from Multiple Sclerosis - Insights

Mayo Clinic has launched a first-in-the-U.S. clinical test that will help patients who recently have been diagnosed with an inflammatory demyelinating disease but may be unsure of the exact disorder.